US 8703791
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
granted A61KA61K31/197A61K31/485
Quick answer
US patent 8703791 (3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/197, A61K31/485, A61K45/06, A61K47/02